SCHEMBL19960397

SCHEMBL19960397

Clc1cccc(-c2nc3ccccc3[nH]2)c1-c1ccc2ccccc2c1Cl

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.59
ALDH1A1 P00352 8/20 0.59
NPC1 O15118 7/20 0.59
KDM4E B2RXH2 7/20 0.59
GPR55 Q9Y2T6 1/20 0.59
AMY1A P0DUB6 2/20 0.50
HPGD P15428 7/20 0.46
HSD17B10 Q99714 4/20 0.46
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 7/20 0.46
NPSR1 Q6W5P4 5/20 0.46
MAPT P10636 3/20 0.46
GLA P06280 2/20 0.46
GAA P10253 2/20 0.46
PKM P14618 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HTT P42858 1/20 0.46
GUSB P08236 2/20 0.45
LMNA P02545 3/20 0.45
MEN1 O00255 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19960367 0.84 RAB9A (0.79) RAB9AALDH1A1NPC1KDM4EGPR55
SCHEMBL19960380 0.83 NPC1 (0.56) RAB9AALDH1A1NPC1KDM4EGPR55
SCHEMBL19960368 0.80 NPC1 (0.76) RAB9AALDH1A1NPC1KDM4EGPR55
SCHEMBL19960391 0.80 NPC1 (0.62) RAB9AALDH1A1NPC1KDM4EGPR55
SCHEMBL27331502 0.78 NPC1 (0.78) RAB9AALDH1A1NPC1KDM4EGPR55
SCHEMBL784353 0.78 NPC1 (0.66) RAB9AALDH1A1NPC1KDM4EGPR55
SCHEMBL29825055 0.78 NPC1 (0.66) RAB9AALDH1A1NPC1KDM4EGPR55
SCHEMBL31677102 0.78 NPC1 (0.66) RAB9AALDH1A1NPC1KDM4EGPR55
SCHEMBL27762363 0.78 NPC1 (0.55) RAB9AALDH1A1NPC1KDM4EGPR55
SCHEMBL14644804 0.78 GUSB (0.56) RAB9AALDH1A1NPC1KDM4EGPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
EP-3266779-B1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEMICAL LTD (KR) 2020-06-03 EP disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 RAB9A 2901/4885ALDH1A1 750/4885NPC1 3974/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 RAB9A 2901/4885ALDH1A1 750/4885NPC1 3974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.